• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究妇女健康倡议中哺乳史与绝经后乳腺癌风险的关联。

Investigating the association of lactation history and postmenopausal breast cancer risk in the Women's Health Initiative.

机构信息

a Food Science and Nutrition, University of Minnesota , St. Paul , Minnesota , USA.

出版信息

Nutr Cancer. 2013;65(7):969-81. doi: 10.1080/01635581.2013.815787. Epub 2013 Oct 15.

DOI:10.1080/01635581.2013.815787
PMID:24127779
Abstract

Prolonged lactation (≥24 mo) has been associated with reduced breast cancer risk. This research examined this association in postmenopausal women in the Women's Health Initiative (WHI) Hormone Trial (HT) and Observational Study (OS). This retrospective cohort analysis included 69,358 predominantly overweight (65.4%), white (83.2%) postmenopausal women without breast cancer. Women in the HT were randomized to 0.625 mg conjugated equine estrogen (CEE), 0.625 CEE + 2.5 mg medroxyprogesterone acetate (CEE/MPA), or placebo. OS participants had no restrictions on hormone use. Lactation history was assessed via WHI Reproductive History Questionnaire. Most women breastfed at least 1 mo (58.0%); 35.4% breastfed 1-2 children; and 6.5% stated having breastfed ≥24mo. Women in the HT-CEE who breastfed their first child between 20-24 yr of age demonstrated a nonsignificant decreased risk of breast cancer (HR: 0.62; 95% CI: 0.38, 1.01). OS participants who reported CEE/MPA hormone use and age of first breastfeeding ≥30 yr showed a significant increased risk of breast cancer (HR: 1.66; 95% CI: 1.14, 2.41). Risk was increased if age of last breastfeeding was ≥35yr (HR: 1.50; 95% CI: 1.05, 2.14). This research did not demonstrate a significantly decreased risk of postmenopausal breast cancer in women who breastfed for ≥24 mo during their lifetime.

摘要

延长哺乳期(≥24 个月)与降低乳腺癌风险有关。这项研究在女性健康倡议(WHI)激素试验(HT)和观察研究(OS)中检查了绝经后妇女的这种关联。这项回顾性队列分析包括 69358 名主要超重(65.4%)、白人(83.2%)、无乳腺癌的绝经后妇女。HT 中的女性被随机分配到 0.625 毫克结合马雌激素(CEE)、0.625 CEE + 2.5 毫克醋酸甲羟孕酮(CEE/MPA)或安慰剂。OS 参与者没有激素使用限制。哺乳史通过 WHI 生殖史问卷进行评估。大多数女性至少母乳喂养 1 个月(58.0%);35.4%母乳喂养 1-2 个孩子;6.5%表示母乳喂养≥24 个月。HT-CEE 中首次母乳喂养年龄在 20-24 岁的女性乳腺癌风险呈非显著降低(HR:0.62;95%CI:0.38,1.01)。报告使用 CEE/MPA 激素和首次母乳喂养年龄≥30 岁的 OS 参与者显示乳腺癌风险显著增加(HR:1.66;95%CI:1.14,2.41)。如果最后一次母乳喂养年龄≥35 岁,则风险增加(HR:1.50;95%CI:1.05,2.14)。这项研究没有表明在一生中母乳喂养≥24 个月的绝经后妇女患乳腺癌的风险显著降低。

相似文献

1
Investigating the association of lactation history and postmenopausal breast cancer risk in the Women's Health Initiative.研究妇女健康倡议中哺乳史与绝经后乳腺癌风险的关联。
Nutr Cancer. 2013;65(7):969-81. doi: 10.1080/01635581.2013.815787. Epub 2013 Oct 15.
2
The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.醋酸甲羟孕酮对雌激素依赖性风险和益处的影响——解读女性健康倡议结果的尝试。
Gynecol Endocrinol. 2006 Jun;22(6):303-17. doi: 10.1080/09513590600717368.
3
The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.女性健康倡议研究及其相关研究:10 年后:临床医生的观点。
J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27.
4
Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.结合马雌激素对子宫切除术后绝经后妇女骨折风险和骨密度的影响:妇女健康倡议随机试验的结果
J Bone Miner Res. 2006 Jun;21(6):817-28. doi: 10.1359/jbmr.060312.
5
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.绝经后女性中雌激素加孕激素的使用与乳腺X线密度:妇女健康倡议随机试验
J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76. doi: 10.1093/jnci/dji279.
6
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.绝经激素治疗与妇女健康倡议随机试验干预和停药后扩展阶段的健康结局。
JAMA. 2013 Oct 2;310(13):1353-68. doi: 10.1001/jama.2013.278040.
7
The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.妇女健康倡议对医疗补助计划中激素替代疗法的影响。
J Womens Health (Larchmt). 2004 Nov;13(9):986-92. doi: 10.1089/jwh.2004.13.986.
8
New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.迫切需要有关激素替代疗法的新证据,经皮绝经后激素疗法在风险和益处方面与口服激素疗法不同。
Maturitas. 2005 Sep 16;52(1):1-10. doi: 10.1016/j.maturitas.2005.05.003.
9
Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.共轭马雌激素与良性增生性乳腺疾病风险:一项随机对照试验。
J Natl Cancer Inst. 2008 Apr 16;100(8):563-71. doi: 10.1093/jnci/djn075. Epub 2008 Apr 8.
10
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.绝经激素治疗与妇女健康倡议随机临床试验长期随访中乳腺癌发病率和死亡率的关系。
JAMA. 2020 Jul 28;324(4):369-380. doi: 10.1001/jama.2020.9482.

引用本文的文献

1
High Expression of the Newly Found Long Noncoding RNA Z38 Promotes Cell Proliferation and Oncogenic Activity in Breast Cancer.新发现的长链非编码RNA Z38的高表达促进乳腺癌细胞增殖和致癌活性。
J Cancer. 2016 Mar 18;7(5):576-86. doi: 10.7150/jca.13117. eCollection 2016.